The Influence of Energy Depletion by Metformin or Hypocaloric Diet on Thyroid Iodine Uptake in Healthy Volunteers: a Randomized Trial.
Adult
Biological Transport
/ drug effects
Diet, Reducing
/ methods
Energy Metabolism
/ drug effects
Healthy Volunteers
/ statistics & numerical data
Humans
Hypoglycemic Agents
/ pharmacology
Iodine Radioisotopes
/ pharmacokinetics
Male
Metformin
/ pharmacology
Thyroid Gland
/ drug effects
Thyrotropin
/ blood
Thyroxine
/ blood
Triiodothyronine
/ blood
Young Adult
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
01 04 2019
01 04 2019
Historique:
received:
10
09
2018
accepted:
17
03
2019
entrez:
2
4
2019
pubmed:
2
4
2019
medline:
6
10
2020
Statut:
epublish
Résumé
Sufficient thyroid iodine uptake is needed to ensure effective radioactive iodine (RAI) treatment, which is mediated by the sodium-iodide symporter (NIS). Activation of AMP-activated-protein-kinase (AMPK), leads to decreased NIS expression and thyroid iodine uptake in in vitro and animal models. Clinically relevant conditions that lead to AMPK activation include metformin use and hypocaloric conditions. Here, we aim to assess the effects of metformin and hypocaloric diet on thyroid iodine uptake in healthy volunteers. Healthy male volunteers were included and randomized. Group 1 (n = 8) received metformin, group 2 (n = 7) followed a hypocaloric diet (1500 kcal/day), superposed on a moderate iodine restriction diet; Baseline measurements included thyroid iodine-123 (I-123) uptake and TSH, fT4, T3 and rT3 levels. After two weeks, thyroid function and I-123 uptake measurements were repeated. Baseline characteristics were similar between groups. Levels of TSH and fT4 were similar after each intervention. T3 decreased after hypocaloric diet and metformin (-0.2 ± 0.19 nmol/L, p = 0.0327; respectively -0.13 ± 0.13 nmol/L, p = 0.0282), resulting in decreased T3/rT3 ratios. There was no significant difference in thyroid I-123 uptake after each intervention. In conclusion, metformin treatment and hypocaloric diet resulted in a significant decrease in T3 levels and T3/rT3 ratios in healthy volunteers, without significant effects on thyroid iodine uptake. We found no indications that metformin or hypocaloric diet will have clinically relevant effects on RAI uptake.
Identifiants
pubmed: 30932012
doi: 10.1038/s41598-019-41997-2
pii: 10.1038/s41598-019-41997-2
pmc: PMC6443645
doi:
Substances chimiques
Hypoglycemic Agents
0
Iodine Radioisotopes
0
Triiodothyronine
06LU7C9H1V
Iodine-123
8YWR746RPQ
Thyrotropin
9002-71-5
Metformin
9100L32L2N
Thyroxine
Q51BO43MG4
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
5396Références
J Clin Invest. 2001 Oct;108(8):1167-74
pubmed: 11602624
Horm Metab Res. 2012 Sep;44(9):650-5
pubmed: 22674476
Thyroid. 2011 Jun;21(6):593-646
pubmed: 21510801
J Clin Endocrinol Metab. 2005 Aug;90(8):4559-65
pubmed: 15886232
Eur Thyroid J. 2015 Sep;4(3):181-8
pubmed: 26558235
Thyroid. 2014 Jan;24(1):78-87
pubmed: 23819433
Nutr Res Pract. 2016 Apr;10(2):167-74
pubmed: 27087900
Eur Thyroid J. 2015 Mar;4(1):48-54
pubmed: 25960962
Laryngoscope. 2006 Nov;116(11):2060-6
pubmed: 17075410
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
Horm Metab Res. 2014 May;46(5):313-7
pubmed: 24691731
J Clin Endocrinol Metab. 1976 Jan;42(1):197-200
pubmed: 1249190
Front Endocrinol (Lausanne). 2017 Jul 20;8:163
pubmed: 28775711
Am J Physiol Cell Physiol. 2011 Jun;300(6):C1291-7
pubmed: 21389275
Am J Clin Nutr. 1984 Jul;40(1):168-82
pubmed: 6741850
Exp Clin Endocrinol Diabetes. 2018 Jun;126(6):342-348
pubmed: 29169197
Int J Obes Relat Metab Disord. 1995 May;19(5):318-24
pubmed: 7647823
J Clin Pathol. 1966 Jul;19(4):389-91
pubmed: 5929341
Eur Thyroid J. 2013 Mar;2(1):22-8
pubmed: 24783035
Eur J Endocrinol. 2013 Sep 17;169(4):521-8
pubmed: 23904275
J Clin Endocrinol Metab. 2003 Jul;88(7):3202-11
pubmed: 12843166
JAMA Intern Med. 2014 Dec;174(12):1955-62
pubmed: 25347323
Eur J Endocrinol. 2012 Nov;167(5):719-26
pubmed: 22956557
Clin Endocrinol (Oxf). 2005 Apr;62(4):487-91
pubmed: 15807881
Tumour Biol. 2015 Aug;36(8):6295-304
pubmed: 25854169
Endocr Rev. 2014 Feb;35(1):106-49
pubmed: 24311738
Genes Dev. 2011 Sep 15;25(18):1895-908
pubmed: 21937710
J Clin Endocrinol Metab. 2009 Jun;94(6):2144-50
pubmed: 19293265
Pharmacol Ther. 2012 Sep;135(3):355-70
pubmed: 22750642
J Clin Endocrinol Metab. 1987 Nov;65(5):829-35
pubmed: 3667881
Thyroid. 2008 Feb;18(2):123-9
pubmed: 18225975
Eur J Endocrinol. 2013 Nov 22;170(1):49-54
pubmed: 24114433
J Clin Invest. 1979 Nov;64(5):1336-47
pubmed: 500814
Diabetes. 2002 Jul;51(7):2074-81
pubmed: 12086935
J Clin Endocrinol Metab. 2013 Aug;98(8):3269-79
pubmed: 23709654
Nature. 1996 Feb 1;379(6564):458-60
pubmed: 8559252
Am J Clin Nutr. 2000 Jun;71(6):1421-32
pubmed: 10837281
J Endocrinol. 1977 May;73(2):395-6
pubmed: 864376